newsfilter
← Latest News
GlobeNewswire·

Vyant Bio Announces Investor Conference Call and Webcast for the First Quarter 2022

CHERRY HILL, N.J., May 10, 2022 (GLOBE NEWSWIRE) -- Vyant Bio, Inc. ("Vyant Bio", "Company") (NASDAQ:VYNT) is an innovative biotechnology company reinventing drug discovery for complex neurodevelopmental and neurodegenerative disorders. The Company's